Home Cart Sign in  
Chemical Structure| 1437321-24-8 Chemical Structure| 1437321-24-8

Structure of CEP-40783
CAS No.: 1437321-24-8

Chemical Structure| 1437321-24-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

RXDX-106 inhibits TAM and c-MET phosphorylation in vitro. This inhibition of TAM and c-MET activation in vitro is accompanied by a decrease in downstream MAPK and PI3K signaling and cell viability. It completely inhibits cellular proliferation and viability at sub-nanomolar concentrations in TAM-expressing cells.

Synonyms: RXDX-106

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CEP-40783

CAS No. :1437321-24-8
Formula : C31H26F2N4O6
M.W : 588.56
SMILES Code : O=C(C1=CN(C(C)C)C(N(C2=CC=C(F)C=C2)C1=O)=O)NC3=CC=C(OC4=CC=NC5=CC(OC)=C(OC)C=C45)C(F)=C3
Synonyms :
RXDX-106
MDL No. :MFCD28502441
InChI Key :FKCWHHYUMFGOPY-UHFFFAOYSA-N
Pubchem ID :71576419

Safety of CEP-40783

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of CEP-40783

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Ba/F3 cells 100 nM 72 hours Screening for drugs that inhibit MET D1228A/Y secondary mutations, CEP-40783 showed inhibitory effects J Hematol Oncol. 2022 Jun 11;15(1):79.
Calu1 5 and 10 μM 72h Evaluate the effect of RXDX106 on cell viability Mol Cancer Res. 2022 Apr 1;20(4):542-555.
Calu1 1 μM 4 hours Evaluate the effect of RXDX106 on global phosphoproteins Mol Cancer Res. 2022 Apr 1;20(4):542-555.
Calu1 100 nM 30 min Evaluate the inhibitory effect of RXDX106 on AXL phosphorylation Mol Cancer Res. 2022 Apr 1;20(4):542-555.
H1299 5 and 10 μM 72h Evaluate the effect of RXDX106 on cell viability Mol Cancer Res. 2022 Apr 1;20(4):542-555.
H1299 1 μM 4 hours Evaluate the effect of RXDX106 on global phosphoproteins Mol Cancer Res. 2022 Apr 1;20(4):542-555.
H1299 100 nM 30 min Evaluate the inhibitory effect of RXDX106 on AXL phosphorylation Mol Cancer Res. 2022 Apr 1;20(4):542-555.

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03454243 Advanced or Metastatic Solid T... More >>umors Less << EARLY_PHASE1 TERMINATED 2018-06-05 START, San Antonio, Texas, 782... More >>29, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.70mL

0.34mL

0.17mL

8.50mL

1.70mL

0.85mL

16.99mL

3.40mL

1.70mL

References

 

Historical Records

Categories